Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection

Blood

Volumn 121, Issue 8, 2013, Pages 1357-1366

  Chi, Chih Yu ^a,b   Chu, Chen Chung ^c,d   Liu, Jing Pei ^e   Lin, Chia Hao ^e   Ho, Mao Wang ^b   Lo, Wen Jyi ^b   Lin, Po Chang ^b   Chen, Hung Jen ^a,f   Chou, Chia Huei ^b   Feng, Jia Yih ^g,h   Fung, Chang Phone ^g   Sher, Yuh Pyng ^a,b   Li, Chi Yuan ^a   Wang, Jen Hsien ^b   Ku, Cheng Lung ^a,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f Division of Pulmonary and Critical Care Medicine   (Taiwan)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON ANTIBODY; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 12;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISSEMINATED NONTUBERCULOUS MYCOBACTERIAL INFECTION; FEMALE; GENE FREQUENCY; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; INFECTION CONTROL; INFECTION RATE; LATENT VIRUS INFECTION; MALE; PRIORITY JOURNAL; SALMONELLOSIS; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

EID: 84874436360     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-08-452482     Document Type: Article

References (46)

1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous myco-bacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367-416.
2. Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis. 2007;45(4):421-427. (Pubitemid 47204456)
3. McGarvey J, Bermudez LE. Pathogenesis of non-tuberculous mycobacteria infections. Clin Chest Med. 2002;23(3):569-583.
4. Puel A, Doffinger R, Natividad A, et al. Autoanti-bodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207(2):291-297.
5. Puel A, Picard C, Lorrot M, et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol. 2008;180(1):647-654.
6. Meager A, Visvalingam K, Peterson P, et al. Anti-interferon autoantibodies in autoimmune polyen-docrinopathy syndrome type 1. PLoS Med. 2006;3(7):e289.
7. Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacte-rial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38(1):e10-e14.
8. Hoflich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood. 2004;103(2):673-675. (Pubitemid 38140103)
9. Patel SY, Ding L, Brown MR, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous my-cobacterial infections. J Immunol. 2005;175(7):4769-4776. (Pubitemid 41362019)
10. Baerlecken N, Jacobs R, Stoll M, Schmidt RE, Witte T. Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis. 2009;49(7):e76-e78.
11. Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115(9):2480-2488. (Pubitemid 41266210)
12. Koya T, Tsubata C, Kagamu H, et al. Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother. 2009;15(2):118-122.
13. Tanaka Y, Hori T, Ito K, Fujita T, Ishikawa T, Uchiyama T. Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma. Intern Med. 2007;46(13):1005-1009. (Pubitemid 47261645)
14. Burbelo PD, Browne SK, Sampaio EP, et al. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neo-plasia. Blood. 2010;116(23):4848-4858.
15. Hellmich B, Csernok E, Schatz H, Gross WL, Schnabel A. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum. 2002;46(9):2384-2391.
16. Rioux JD, Goyette P, Vyse TJ, et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A. 2009;106(44):18680-18685.
17. Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev. 2009;22(2):370-385.
18. Pfyffer GE. Mycobacterium: General characteristics, laboratory detection, and staining procedures. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of Clinical Microbiology. Vol 1. Washington, DC: American Society for Microbiology; 2007:543-572.
19. Brown-Elliott BA, Wallace R J J. Mycobacterium: clinical and laboratory characteristics of rapidly growing mycobacteria. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of Clinical Microbiology. Vol 1. Washington, DC: American Society of Microbiology; 2007:589-600.
20. Vincent V, Gutierrez MC. Mycobacterium: laboratory characteristics of slowly growing mycobacte-ria. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of Clinical Microbiology. Vol 1. Washington, DC: American Society of Microbiology; 2007:573-588.
21. Cereb N, Maye P, Lee S, Kong Y, Yang S. Locus-Specific amplification of HLA class I gene from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B and-C alleles. Tissue Antigens. 1995;45:1-11.
22. Johnston-Dow L, Bengtson A, Scheltinga S, et al. DNA sequencing based typing of HLA-A. In: Charron D, ed. 12th International Hisocompatibil-ity workshop and conference. Paris, France: EDK Medical and Scientific International Publisher; 1997:250-254.
23. * genes sequence-based typing. In: Tilanus MGJ, Hansen JA, Hurley CK, eds. IHWG Technical Manual: Genomic Analysis of the Human MHC DNA-Based Typing for HLAAlleles and Linked Polymorphisms: International Histocompatibility Working Group; Seattle, WA: Fred Hutchinson Cancer Research Center; 2002: Chapter 28:1-14.
24. Kotsch K, Wehling J, Kohler S, Blasczyk R. Sequencing of HLA class I genes based on the conserved diversity of the noncoding regions: sequencing-based typing of the HLA-A gene. Tissue Antigens. 1997;50(2):178-191. (Pubitemid 27326284)
25. Dunn PJ. Chapter 12-C: Sequencing-based typing for HLA-DQB1. In: Tilanus MGJ, Hansen JA, Hurley CK, eds. IHWG Technical Manual: Genomic Analysis of the Human MHC DNA-Based Typing for HLA Alleles and Linked Polymorphisms: International Histocompatibility Working Group; Seattle, WA: Fred Hutchinson Cancer Research Center; 2002:1-4.
26. Van Dijk A, Melchers R, Hilkes Y, Rozemuller E, Tilanus M. HLA-DRB sequencing-based typing: an improved protocol which shows complete DRB exon 2 sequences and includes exon 3 of HLA-DRB4/5. Tissue Antigens. 2007;69(Suppl 1):61-63. (Pubitemid 46625853)
27. Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291-455.
28. Chu CC, Lee HL, Trejaut J, Chang H, Lin M. HLA-A, -B, -Cw and-DRB1 alleles frequencies in a Minnan population from Taiwan. Hum Immunol. 2004;65(9-10):1123-1128.
29. Gjertson DW, Lee SL. HLA-A/B and-DRB1/DQB1 allele-level haplotype frequencies. In: Gjertson DW, Terasaki PI, eds. HLA 1998. Lenexa, KS: American Society for Histocompatibility and Immunognentics; 1998:366-450.
30. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 1998;280(5368):1432-1435. (Pubitemid 28264836)
31. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med. 1996;335(26):1956-1961.
32. Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacte-rial diseases. J Allergy Clin Immunol. 2008;122(6):1043-1051, quiz 1052-1053.
33. Franchimont D. Overview of the actions of gluco-corticoids on the immune response: a good model to characterize new pathways of immuno-suppression for new treatment strategies. Ann N YAcad Sci. 2004;1024:124-137. (Pubitemid 38879597)
34. Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725-734.
35. Gebe JA, Swanson E, Kwok WW. HLA class II peptide-binding and autoimmunity. Tissue Antigens. 2002;59(2):78-87. (Pubitemid 34620547)
36. Goldfeld AE, Delgado JC, Thim S, et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA. 1998;279(3):226-228. (Pubitemid 28133786)
37. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefre-quencies.net. Tissue Antigens. 2003;61(5):403-407. (Pubitemid 36605674)
38. Trinchieri G. Type I interferon: friend or foe? J Exp Med. 2010;207(10):2053-2063.
39. Zhang SY, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev. 2008;226:29-40.
40. Dorman SE, Uzel G, Roesler J, et al. Viral infections in interferon-gamma receptor deficiency. J Pediatr. 1999;135(5):640-643. (Pubitemid 30180456)
41. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010;48(Suppl 1):S2-S7.
42. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39(3):342-348. (Pubitemid 39050481)
43. Lin YH, Huang LM, Chang IS, et al. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine. 2010;28(5):1217-1220.
44. Sen N, Sommer M, Che X, White K, Ruyechan WT, Arvin AM. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J Virol. 2010;84(18):9240-9253.
45. Roesler J, Hedrich C, Laass MW, Heyne K, Rosen-Wolff A. Meningoencephalitis caused by varicella-zoster virus reactivation in a child with dominant partial interferon-gamma receptor-1 deficiency. Pediatr Infect Dis J. 2011;30(3):265-266.
46. Taurog JD. The role of HLA-B27 in spondyloar-thritis. J Rheumatol. 2010;37(12):2606-2616.